Gene · 3316
Papers3,243
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,243
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| "All for One and One for All": The Secreted Heat Shock Protein gp96-Ig Based Vaccines. | Cells | 2023 | 38201276 | PubTator, text mining | PubMed |
| Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases. | Cells | 2023 | 38201212 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Expression of Preferentially Expressed Antigen in Melanoma, a Cancer/Testis Antigen, in Carcinoma In Situ of the Urinary Tract. | Diagnostics (Basel) | 2023 | 38132219 | PubTator, text mining | PubMed |
| Imidacloprid Induces Lysosomal Dysfunction and Cell Death in Human Astrocytes and Fibroblasts-Environmental Implication of a Clinical Case Report. | Cells | 2023 | 38132092 | PubTator, text mining | PubMed |
| Nkx2.5: a crucial regulator of cardiac development, regeneration and diseases. | Front Cardiovasc Med | 2023 | 38124890 | PubTator, text mining | PubMed |
Upregulation of Hsp27 via further inhibition of histone H2A ubiquitination confers protection against myocardial ischemia/reperfusion injury by promoting glycolysis and enhancing mitochondrial function. | Cell Death Discov | 2023 | 38114486 | PubTator, text mining | PubMed |
| Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles. | ACS Mater Au | 2023 | 38089659 | PubTator, text mining | PubMed |
| Editorial: Perspectives in pharmacological therapy targeting cellular metabolic pathways in respiratory diseases. | Front Pharmacol | 2023 | 38089050 | PubTator, text mining | PubMed |
| Mechanistic insights into the anti-restenotic effects of HSP27 and HO1 modulated by reconstituted HDL on neointimal hyperplasia. | Sci Rep | 2023 | 38087008 | PubTator, text mining | PubMed |
| Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions. | Front Genet | 2023 | 38075698 | PubTator, text mining | PubMed |
| The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects. | Nutrients | 2023 | 38068715 | PubTator, text mining | PubMed |
| Hsf1 and the molecular chaperone Hsp90 support a 'rewiring stress response' leading to an adaptive cell size increase in chronic stress. | Elife | 2023 | 38059913 | PubTator, text mining | PubMed |
| Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants. | Mol Cell Biol | 2023 | 38051092 | PubTator, text mining | PubMed |
| Emerging role of mesenchymal stromal cells in gynecologic cancer therapy. | Stem Cell Res Ther | 2023 | 38049868 | PubTator, text mining | PubMed |
| Progress in the clinical treatment of keloids. | Front Med (Lausanne) | 2023 | 38046417 | PubTator, text mining | PubMed |
| Extracellular vesicles modulate key signalling pathways in refractory wound healing. | Burns Trauma | 2023 | 38026441 | PubTator, text mining | PubMed |
| Mild photothermal therapy assist in promoting bone repair: Related mechanism and materials. | Mater Today Bio | 2023 | 38024841 | PubTator, text mining | PubMed |
| Phototherapy techniques for the management of musculoskeletal disorders: strategies and recent advances. | Biomater Res | 2023 | 38017585 | PubTator, text mining | PubMed |
| Mild heat treatment in vitro potentiates human adipose stem cells: delayed aging and improved quality for long term culture. | Biomater Res | 2023 | 38008757 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3316/papers?page=6